David A. Wentz served as the CEO of USANA Health Sciences, Inc., a leader in health and wellness products, from 2008 until 2016. He has a background in bioengineering with a B.S. degree from the University of California, San Diego....

David A. Wentz served as the CEO of USANA Health Sciences, Inc., a leader in health and wellness products, from 2008 until 2016. He has a background in bioengineering with a B.S. degree from the University of California, San Diego. Wentz transitioned from a part-time role in USANA, where he started in 1992, to holding several key leadership positions including President before taking on the CEO role. Under his guidance, USANA adopted a co-CEO structure alongside Kevin Guest for a brief period in 2015, showcasing a collaborative approach to leadership. Wentz's tenure saw a focus on expanding global operations and strategic initiatives. He made a personal decision to step down in late 2016 to spend more time with his family. Notably, his total compensation fluctuated during his time as CEO, peaking at around $828,704 in 2013 largely due to performance bonuses tied to net sales growth and profitability. His leadership at USANA reflects a commitment to aligning company performance with individual roles. Wentz is also known to be the son of the company's founder, Dr. Myron Wentz, which adds a personal family legacy to his professional journey.

Quick Links

1. Rivals

2. Holdings

3. Insider Trading

4. Compensation History

5. Other USANA Health Sciences CEOs

U

David A. Wentz

Ex-CEO of USANA Health Sciences

Education

B.S. in Bioengineering from the University of California, San Diego

Field of Expertise

Business & Management

Sector of Economy

Consumer Defensive

Born

January 1, 1970 - 55 years ago

CEO of USANA Health Sciences for

7 years 1 month (Jul 2008 - Aug 2015)

Previous Experience

Various management positions within USANA since 1992

Rivals

Competitors/colleagues of David A. Wentz

Holdings

See how much did David A. Wentz make over time.

At his peak, David A. Wentz held a significant stake in USANA Health Sciences. His net worth was largely tied to the company's stock performance, which influenced his compensation. In 2015, he had stock options worth estimated millions, although the...

At his peak, David A. Wentz held a significant stake in USANA Health Sciences. His net worth was largely tied to the company's stock performance, which influenced his compensation. In 2015, he had stock options worth estimated millions, although the values fluctuated greatly year to year based on the company's success. During his time, he was granted millions worth of stock-settled stock appreciation rights (SSARs) and saw his total compensation jump in profitable years, with a notable high of $828,704 in 2013 when USANA performed exceptionally well. However, by 2015 his holdings and involvement diminished as he balanced executive responsibilities with family commitments.

Total Stock Sold

$9.85M

USNA

$9.85M

532,124 USNA shares

What if they kept their stock?

If David A. Wentz didn't sell their stock, today they would have:
Extra USNA532,124 shares worth $42.80M.
This is 334.65% and $32.95M more than what they got when they sold the stock.

Charitable Transactions

USNA

218,470 shares

USNA

Recent Charitable Transactions

USNA

53,250 shares

USNA

Jan 2, 2016

Charity

USNA

5,410 shares

USNA

Jan 3, 2015

Charity

USNA

10,000 shares

USNA

Dec 29, 2012

Charity

USNA

375 shares

USNA

Jul 27, 2012

Charity

USNA

8,600 shares

USNA

Dec 31, 2011

Charity

USNA

4,400 shares

USNA

Jan 1, 2011

Charity

Insider Trading

See recent insider trades of David A. Wentz.

USNA

$1.41M

USNA at $131.05/share

Aug 16, 2016

Sale

USNA

$1.25M

USNA at $125.04/share

Jun 3, 2016

Sale

USNA

53,250 shares

USNA

Jan 2, 2016

Charity

USNA

$783.52K

USNA at $130.59/share

Dec 15, 2015

Sale

USNA

$2.33M

USNA at $129.00/share

May 20, 2015

Sale

USNA

$502.67K

USNA at $133.83/share

May 7, 2015

Sale

USNA

5,410 shares

USNA

Jan 3, 2015

Charity

USNA

$2.27M

USNA at $114.68/share

Oct 31, 2014

Sale

USNA

$376.83K

USNA at $73.30/share

Aug 25, 2014

Sale

USNA

$400.27K

USNA at $75.51/share

Jun 12, 2014

Sale

Compensation History

See how much did David A. Wentz make over time.

David A. Wentz's compensation as CEO of USANA Health Sciences varied greatly over the years. In 2015, he earned a total of $439,523, with most of that being a base salary of $428,423. He did not receive any bonuses that year. Earlier in 2013, he took home his highest compensation of $828,704, which included a significant performance bonus due to strong company profits. Wentz's packages showed how his pay aligned closely with USANA's performance metrics, like sales growth and profitability. For several years, the overall strategy was to offer a competitive compensation plan that reflected individual and company success. His role ended in 2016 as he stepped down to focus on family and other personal initiatives.

Year

2015

Total Compensation

$437.52K

Salary

$428.42K

Board Justification

The compensation philosophy is designed to attract and retain executives through a competitive compensation plan that ties compensation to individual and company performance.

Bonus

$0.00

Board Justification

No cash bonus was awarded for the year 2015 as per the summary compensation table.

Other

$9.10K

Board Justification

This amount includes employer's matching contribution to the Executive's 401(k) plan.

Restricted Stock

$0.00(0 N/A)

Board Justification

No stock awards were vested in 2015 as per the summary compensation table.

Performance Metrics

The performance metrics for determining compensation in 2015 included growth in net sales and profitability.

Other USANA Health Sciences CEOs

Here are other CEOs of USANA Health Sciences

Kevin G. Guest

Ex-CEO of USANA Health Sciences

August 2015 - July 2023